TickerFacts.

A business in context

BBIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001140361-26-035055 · Items 8.01,9.01

  2. 4 · Ownership change

    Report date 2026-08-18 · 0001470831-26-000848

  3. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000837

  4. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000836

  5. 4 · Ownership change

    Report date 2026-08-16 · 0001470831-26-000835

  6. 8-K · Current report

    Report date 2026-08-13 · 0001140361-26-033282 · Items 1.01,8.01,9.01

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001743881-26-000027

  8. 8-K · Current report

    Report date 2026-08-10 · 0001743881-26-000026 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-07-30 · 0001470831-26-000745

  10. 8-K · Current report

    Report date 2026-07-22 · 0001140361-26-029291 · Items 8.01,9.01

  11. 4 · Ownership change

    Report date 2026-07-09 · 0001470831-26-000709

  12. 4 · Ownership change

    Report date 2026-07-09 · 0001470831-26-000708

  13. 8-K · Current report

    Report date 2026-07-01 · 0001140361-26-027445 · Items 1.01,3.02,3.03,5.03,7.01,9.01

  14. 8-K · Current report

    Report date 2026-06-22 · 0001140361-26-026506 · Items 5.02,5.07,9.01

  15. 4 · Ownership change

    Report date 2026-06-22 · 0001470831-26-000636

  16. 8-K · Current report

    Report date 2026-05-27 · 0001140361-26-022979 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-05-12 · 0001140361-26-021036 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-05-07 · 0001140361-26-019761 · Items 1.01,1.02,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001743881-26-000019

  20. 8-K · Current report

    Report date 2026-05-06 · 0001743881-26-000018 · Items 2.02,8.01

  21. DEF 14A · Proxy statement

    Report date 2026-06-22 · 0001140361-26-016723

  22. 8-K · Current report

    Report date 2026-03-30 · 0001140361-26-011991 · Items 8.01,9.01

  23. 10-K · Annual report

    Report date 2025-12-31 · 0001743881-26-000009

  24. 8-K · Current report

    Report date 2026-02-24 · 0001743881-26-000008 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-02-12 · 0001140361-26-004995 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2026-01-14 · 0001140361-26-001843 · Items 1.01,2.03,3.02,8.01,9.01

  27. 8-K · Current report

    Report date 2026-01-12 · 0001140361-26-000971 · Items 2.02,7.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001743881-25-000012

  29. 8-K · Current report

    Report date 2025-10-29 · 0001743881-25-000010 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-10-29 · 0001140361-25-039705 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-10-27 · 0001140361-25-039463 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103192

  33. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-102985 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-06-27 · 0001140361-25-024413 · Items 1.01,2.03

  35. 8-K · Current report

    Report date 2025-06-20 · 0001140361-25-023362 · Items 3.03,5.03,5.07,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-20 · 0001140361-25-016452

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-060314

  38. 8-K · Current report

    Report date 2025-04-29 · 0000950170-25-060085 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-03-17 · 0001140361-25-009063 · Items 5.02,7.01,9.01

  40. 8-K · Current report

    Report date 2025-02-24 · 0001140361-25-006524 · Items 1.01,1.02,2.03,3.02,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 52 transaction rows52SGrant / award: 24 transaction rows24AExercise / conversion: 20 transaction rows20MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

100 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-24
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock37167.070.0
2026-06-24
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17167.016.75
2026-06-24
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock20000.08.45
2026-06-24
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
17167.00.0
2026-06-24
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
20000.00.0
2026-06-23
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2196.068.57
2026-06-23
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2196.068.57
2026-06-22
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Cook Jennifer E.
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock2808.041.73
2026-06-22
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2808.068.0
2026-06-22
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Valantine Hannah
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2808.00.0
2026-06-22
2026-06-24
Lo AndrewA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Lo AndrewA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
HOMCY CHARLES JA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
HOMCY CHARLES JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
AGUIAR ERICA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
AGUIAR ERICA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
DANIELS RONALD JA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
DANIELS RONALD JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Ellis AndreaA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Ellis AndreaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Hassan FredA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Hassan FredA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
MOMTAZEE JAMES CA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
MOMTAZEE JAMES CA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
MCCORMICK FRANKA · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
MCCORMICK FRANKA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Dachille Douglas A.A · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Dachille Douglas A.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-22
2026-06-24
Satvat Ali J.A · Grant / award
Acquired
Common Stock3990.00.0
2026-06-22
2026-06-24
Satvat Ali J.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5277.00.0
2026-06-20
2026-06-23
HOMCY CHARLES JF · Tax / exercise payment
Disposed
Common Stock788.066.27
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1503.067.14
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock65921.08.45
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17167.016.75
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock88737.066.62
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
17167.00.0
2026-06-15
2026-06-17
Cook Jennifer E.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
65921.00.0
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7147.067.2
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4415.068.96
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4416.068.96
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8437.067.88
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8437.067.88
2026-06-05
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7148.067.2
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2200.065.72
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1429.066.72
2026-06-04
2026-06-08
Kumar Neil
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15921.067.74

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001743881BridgeBio Pharma, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • BridgeBio Pharma LLC · former SEC name · 2018-06-19 to 2019-05-16

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$221.90M$236.21M
2023-12-31$9.30M$10.19M
2022-12-31$77.65M$88.58M
2021-12-31$69.72M$85.90M
2020-12-31$8.25M$10.64M
2019-12-31$40.56M$52.97M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗